First vaccine against hand-foot-mouth disease waiting for approval
The third trial of the vaccine against hand-foot-mouth disease (HFMD) caused by the Non-Mouse-Adapted Enterovirus 71 (EV71) strain has been completed and is waiting for the Ministry of Health's approval, said Vice Director of Clinical Research Unit of Pasteur Institute of Ho Chi Minh city Nguyen Trong Toan.
At the Department of Infection and Neurology of Children's Hospital 1 in HCM City (Photo: VNA)
HCM City (VNA) – The third trial of the vaccine against hand-foot-mouth disease (HFMD) caused by the Non-Mouse-Adapted Enterovirus 71 (EV71) strain has been completed and is waiting for the Ministry of Health'sapproval, said Vice Director of ClinicalResearch Unit of Pasteur Institute of Ho Chi Minh city Nguyen Trong Toan.
According to Dr. Toan, the vaccine was first researched by the NationalHealth Research Institute (NHRI) of Taiwan (China), then continued to betransferred and developed through clinical trials.
From 2019 to 2021, the third clinical trial was conducted on3,049 children aged two months to six years in Vietnam and Taiwan, with the numberof Vietnamese children accounting for 80%.
In Vietnam, children in six districts of the Mekong Deltaprovinces of Tien Giang and Dong Thap were selected for clinical trials becausethese localities recorded high rates of HFMD.
The trial in Vietnam had to take longer than scheduled dueto the impact of COVID-19, Toan said.
Findings show that the protective efficacy of the vaccine inhelping defend against the EV71 strain - the most dangerous virus strain thatcauses HFMD with a high risk of death, is 96.8%. During the study period, therewere no cases of HFMD recorded among the children who received the vaccine.
Researchers have not detected any post-vaccination anaphylaxis.
Based on the clinical trial results, the production unitsubmitted a dossier to the Ministry of Health for approval, Toan said.
If approved, this will be the first HFMD vaccine in Vietnam againstEV71 strain, he noted./.
The Ministry of Health has ordered preventive medicine units and facilities across the nation to strengthen hand-foot-mouth disease (HFMD) prevention in response to the increase in the number of cases in major cities across the nation.
Vaccinations must take place safely and effectively, particularly in remote disadvantaged areas where vaccination coverage remained modest, Deputy Health Minister Do Xuan Tuyen said on September 21.
Local hospitals have been supplied with 6,000 bottles of Plasma-derived Intravenous Immunoglobulin (IVIG) for treatment of hand, foot and mouth disease (HFMD) which were delivered to Vietnam last week, according to the Drug Administration of Vietnam under the Ministry of Health.
Many new kinds of vaccines will be included in the national expanded programme on immunisation (EPI) in the coming time, said Dr. Dang Thanh Huyen, deputy head of the EPI Office under the Ministry of Health, on July 10.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
At the Department of Infection and Neurology of Children's Hospital 1 in HCM City (Photo: VNA) 
